Quick Answer
USANA HEALTH SCIENCES INC reported Revenue (ASC 606) of $925.26 million for fiscal year 2025.
USANA HEALTH SCIENCES INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $925.26M | +8.3% |
| 2024 | $854.50M | -7.2% |
| 2023 | $921.01M | -7.8% |
| 2022 | $998.60M | -15.8% |
| 2021 | $1.19B | +4.6% |
| 2020 | $1.13B | +7.0% |
| 2019 | $1.06B | -10.8% |
| 2018 | $1.19B | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $213.67M | +6.7% | -9.4% |
| June 30, 2025 | $235.85M | +10.8% | -5.5% |
| March 31, 2025 | $249.54M | +9.5% | +24.6% |
| September 30, 2024 | $200.22M | -6.2% | -5.9% |
| June 30, 2024 | $212.87M | -10.6% | -6.6% |
| March 31, 2024 | $227.80M | -8.3% | +6.8% |
| September 30, 2023 | $213.37M | -8.5% | -10.4% |
| June 30, 2023 | $238.20M | -9.9% | -4.1% |
- USANA HEALTH SCIENCES INC showed an increase of +8.3% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2018–2025 period, USANA HEALTH SCIENCES INC’s revenue (asc 606) has declined by 22.2% (from $1.19 billion to $925.26 million).
- The most recent figure is from USANA HEALTH SCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: